RAPP smart money
Rapport Therapeutics, INC. (RAPP): 2 insider buys, 8 top funds holding it, 2 ETF changes in the public filings.
Insider buys, 12 months$20.5M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-10-30 | Healy James | Director | $20.4M | $21.0 |
| 2026-10-23 | Sanchez Ramiro | Director | $98k | $27.35 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 46 | Sofinnova Investments, INC. | 3.16% | $64M | |
| 47 | Casdin Capital, LLC | BUY | 0.29% | $7M |
| 49 | Johnson & Johnson | 7.87% | $60M | |
| 50 | Siren, L.L.C. | 0.51% | $22M | |
| 51 | Dafna Capital Management LLC | ADD +89% | 1.02% | $5M |
| 71 | Baker Bros. Advisors LP | 0.25% | $52M | |
| 72 | Sphera Funds Management LTD. | BUY | 0.51% | $3M |
| 76 | Polar Capital Holdings PLC | 0.15% | $54M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETF | ADD | +$600k | 2026-06-30 |
| Ishares U.S. Pharmaceuticals ETF | TRIM | −$200k | 2026-06-30 |